June 29, 2020

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for Voriconazole Inhalation Powder

June 18, 2020

TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder

May 14, 2020

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

May 7, 2020

TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020

April 30, 2020

TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

April 17, 2020

TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

April 15, 2020

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform

April 9, 2020

TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine

April 6, 2020

KXAN-TV Austin, TX: Can an existing drug be re-purposed to treat COVID-19 patients? UT researchers working to find out

April 6, 2020

UT News: New Delivery Method Could Make Niclosamide an Effective Antiviral to Treat COVID-19